Mode of action of atypical neuroleptics in relation to the phencyclidine model of schizophrenia: Role of 5-HT2 receptor and αl-adrenoreceptor antagonism

Journal of Clinical Psychopharmacology

Volumn 15, Issue 1, 1995, Pages 11S-18S

  Svensson, Torgny H ^a   Mathe, Jan M ^a   Andersson, Jonas L ^a   Nomikos, George G ^a   Hildebrand, Bengt E ^a   Marcus, Monica ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; AMPEROZIDE; CLOZAPINE; DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PHENCYCLIDINE; PRAZOSIN; RACLOPRIDE; RITANSERIN; SEROTONIN RECEPTOR;

CONFERENCE PAPER; DOPAMINERGIC SYSTEM; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; PRIORITY JOURNAL; SCHIZOPHRENIA; SUBCUTANEOUS DRUG ADMINISTRATION;

ACTION POTENTIALS; ADRENERGIC ALPHA-ANTAGONISTS; ANALYSIS OF VARIANCE; ANIMAL; ANTIPSYCHOTIC AGENTS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; MOTOR ACTIVITY; NEURONS; PHENCYCLIDINE; RATS; SCHIZOPHRENIA; SEROTONIN ANTAGONISTS; SUPPORT, NON-U.S. GOV'T; TIME FACTORS;

EID: 0028836313     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. 2 blocker. Drug Dev Res 1986;8:205–11.
2. 2 receptor blockers in the treatment of chronic schizophrenia. Clin Neuropharmacol 1986;9(suppl 4):325–7.
3. 2 receptor block agent. Curr Ther Res 1986;40:492–9.
4. Gelders YG. Thymosthenic agents, a novel approach in the treatment of schizophrenia. Br J Psychiatry 1989;155:33–6.
5. 2 receptor antagonist, activates midbrain dopamine neurons by blocking serotonergic inhibition. Psychopharmacology 1989;98:45–50.
6. Carlsson A. The current status of the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 1988;1:179–203.
7. Angrist B, Peselow E, Rubinstein M, Rotrosen J. Partial improvement in negative schizophrenic symptoms after amphetamine. Psychopharmacology 1983;78:128–30.
8. van Kammen DP, Boronow JJ. Dextro-amphetamine diminishes negative symptoms in schizophrenia. Int Clin Psychopharmacol 1988;3:111–21.
9. Karoum F, Karson CN, Bigelow LB, Lawson WB, Wyatt RJ. Preliminary evidence of reduced combined output of dopamine and its metabolites in chronic schizophrenia. Arch Gen Psychiatry 1987;44:604–7.
10. van Kammen DP, van Kammen WB, Mann LS, Seppala T, Linnoila M. Dopamine metabolism in the cerebrospinal fluid of drug-free schizophrenic patients with and without cortical atrophy. Arch Gen Psychiatry 1986;43:978–83.
11. Mackay AVP. Discussion: positive and negative schizophrenic symptoms and the role of dopamine. Br J Psychiatry 1980;137:382–6.
12. Friedhoff M. A dopamine-dependent restitutive system for the maintenance of mental normalcy. Ann NY Acad Sci 1986;863:47–52.
13. Wiesel F-A, Nordström A-L, Farde L, Eriksson B. An open clinical and biochemical trial of ritanserin in acute patients with schizoqhrenia. Psychopharmacology 1994;144:31–8.
14. Nauta WJH. Behavioral alterations in patients with basal ganglia lesions. In: Yahr MD, ed. The basal ganglia. New York: Raven Press, 1976:177–180.
15. Javitt DC, Zukin SR. Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 1991;148:1301–8.
16. Cohen BM, Lipinski JF. In vivo potencies of antipsychotic drugs in blocking alpha, and dopamine D2 receptors: implications for drug mechanism of action. Life Sci 1986;39:2571–80.
17. Peroutka SJ, Snyder SH. Relationship of neuroleptic drug effects at brain dopamine, serotonin, alpha adrenergic, and histamine receptors to clinical potency. Am J Psychiatry 1980;137:1518–22.
18. Grenhoff J, Nisell M, Ferré S, Aston-Jones G, Svensson TH. Noradrenergic modulation of dopamine cell firing elicited by stimulation of the locus coeruleus in the rat. J Neural Transm 1993;93:11–25.
19. Grenhoff J, Svensson TH. Prazosin modulates the firing pattern of dopamine neurons in rat ventral tegmental area. Eur J Pharmacol 1993;233:79–84.
20. Andersson JL, Marcus M, Nomikos GG, Svensson TH. Prazosin modulates the changes in firing pattern and transmitter release induced by raclopride in the mesolimbic, but not the nigrostriatal dopaminergic system. Naunyn-Schmeidebergs Arch Pharmacol 1994;349:236–43.
21. Murase S, Mathé JM, Grenhoff J, Svensson TH. Effects of dizocilpine (MK-801) on rat midbrain dopamine cell activity: differential actions on firing pattern related to anatomical localization. J Neural Transm 1993;91:13–25.
22. Gonon FG. Nonlinear relationship between impulse flow and dopamine released by rat midbrain dopaminergic neurons as studied by in vivo electrochemistry. Neuroscience 1988;24:19–28.
23. Nomikos GG, Iurlo M, Andersson JL, Kimura K, Svensson TH. Systemic administration of amperozide, a new atypical antipsychotic drug, preferentially increases dopamine release in the rat medial nrefrontal cortex. Psychopharmacology 1994;115:147–56.
24. Ericsson E, Samuelsson J, Ahlénius S. Photocell measurements of rat motor activity. J Pharmacol Meth 1991;25:111–22.
25. Grace AA, Bunney BS. Intracellular and extracellular electrophysiology of nigral dopamine neurons-1. Identification and characterization. Neuroscience 1983;10:301–15.
26. Bunney BS, Walters JR, Roth RH, Aghajanian GK. Dopaminergic neurons: effects of antipsychotic drugs and amphetamine on single cell activity. J Pharmacol Exp Ther 1973;185:560–71.
27. Grenhoff J, Tung C-S, Svensson TH. The excitatory amino acid antagonist kynurenate induces pacemaker-like firing of dopamine neurons in rat ventral tegmental area in vivo. Acta Physiol Scand 1988;134:567–8.
28. Charléty PJ, Grenhoff J, Chergui K, De La Chapelle B, Buda M, Svensson TH, Chouvet G. Burst firing of mesencephalic dopamine neurons is inhibited by somatodendritic application of kynurenate. Acta Physiol Scand 1991;142:105–12.
29. Chergui K, Charléty PJ, Akaoka CF, Saunier J-L, Bnmet M, Buda M, Svensson TH, Chouvet G. Tonic activation of NMDA receptors causes spontaneous burst discharge of rat midbrain dopamine neurons in vivo. Eur J Neurosci 1993;5:137–44.
30. Bean AJ, Roth RH. Extracellular dopamine and neurotensin in rat prefrontal cortex in vivo: effects of median forebrain bundle stimulation frequency, stimulation pattern, and dopamine autoreceptors. J Neurosci 1991;11:2694–702.
31. Gariano RF, Groves PM. Burst firing induced in midbrain dopamine neurons by stimulation of medial prefrontal and anterior cingulate cortices. Brain Res 1988;462:194–8.
32. Svensson TH, Tung C-S. Local cooling of prefrontal cortex induces pacemaker-like firing of dopamine neurons in rat ventral tegmental area in vivo. Acta Physiol Scand 1989;136:135–6.
33. Murase S, Grenhoff J, Chouvet G, Gonon FG, Svensson TH. Prefrontal cortex regulates burst firing and transmitter release in ratmesolimbic dopamine neurons studied in vivo. Neurosci Lett 1993;157:53–6.
34. Schultz W, Apicella P, Ljungberg T. Responses of monkey dopamine neurons to reward and conditioned stimuli during successive steps of learning a delayed response task. J Neurosci 1993;13:900–13.
35. Brozoski T, Brown RM, Rosvold HE, Goldman PS. Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey. Science 1979;205:929–32.
36. Sawaguchi T, Matsumura M, Kubota K. Dopamine enhances the neuronal activity of spatial short-term memory task in the primate prefrontal cortex. Neurosci Res 1988;5:465–73.
37. Sawaguchi T, Matsumura M, Kubota K. Effects of dopamine antagonists on neuronal activity to delayed response task in monkey prefrontal cortex. J Neurophysiol 1990;63:1401–12.
38. Ingvar D. Evidence for frontal/prefrontal cortical dysfunction in chronic schizophrenia: the phenomenon of “hypofrontality” reconsidered. In: Heimchen H, Henn FA, eds. Biological perspectives of schizophrenia. Chichester: John Wiley & Sons, 1987:201–11.
39. Weinberger DR. Schizophrenia and the frontal lobe. Trends Neurosci 1988;11:367–70.
40. Volkow ND, Hitzemann R, Wang G-J, Fowler JS, Wolf AP, Dewey SL, Handlesman L. Long-term frontal brain metabolic changes in chronic cocaine abusers. Synapse 1992;11:184–90.
41. Wu JC, Buchsbaum MS, Bunney WE. Positron emission tomography study of phencyclidine users as a possible drug model of schizophrenia. Jpn J Psychopharmacol 1991;11:47–8.
42. 2 antagonist ritanserin blocks the effects of prefrontal cortex inactivation on rat A10 dopamine neurons in vivo. Acta Physiol Scand 1989;136:497℃8.
43. Grenhoff J, Tung C-S, Ugedo L, Svensson TH. Effects of amperozide, a putative antipsychotic drug, on rat midbrain dopamine neurons recorded in vivo. Pharmacol Toxicol 1990;(suppl 1):29–33.
44. C receptors in pyramidal cells and 5-HT2 receptors in interneurons. Synapse 1991;9:208–18.
45. Gellman RL, Aghajanian GK. Pyramidal cells in pirifonn cortex receive a convergence of inputs from monoamine activated GABAergic interneurons. Brain Res 1993;600:63–73.
46. Pawlowski L, Mathé JM, Svensson TH. Phencyclidine activates rat A10 dopamine neurons but reduces burst activity and causes regularization of firing. Acta Physiol Scand 1990;139:529–30.
47. 2 receptor antagonists modulate PCP or MK-801 induced distortions of A10 dopamine neuronal flring pattern. Psychopharmacology 1994;10:141S.
48. Moghaddam B, Bunney BS. Acute effects of typical and atypical antipsychotic drugs on the release of dopamine from prefrontal cortex, nucleus accumbens, and striatum of the rat: an in vivo microdialysis study. J Neurochem 1990;54:1755–60.
49. Deutch AY. Prefrontal cortical dopamine systems and the elaboration of functional corticostriatal circuits: implications for schizophrenia and Parkinson’s disease. J Neural Transm 1993;91:197–221.
50. Lipska BK, Jaskiw GE, Chrapusta S, Karoum F, Weinberger DR. Ibotenic acid lesion of the ventral hippocampus differentially affects dopamine and its metabolites in the nucleus accumbens and prefrontal cortex in the rat. Brain Res 1992;585:1–6.
51. Sudciath RL, Christison GW, Torrey EF, Casanova EF, Weinberger DR. Antatomical abnormalities in the brains of monozygotic twins discordant for schizophrenia. N Engl J Med 1990;322:789–94.
52. Servan-Schreiber D, Printz HW, Cohen JD. A network model of catecholamine effects: gain, signal-to-noise ratio, and behavior. Science 1990;249:892–5.
53. Grenhoff J, Svensson TH. Clonidine modulates dopamine cell firing in rat ventral tegmental area. Eur J Pharmacol 1989;165:11–8.